Health and Healthcare
Weekend of Cancer Data at AACR Ahead of ASCO (ALTH, AMGN, ARIA, ARRY, AZN, BIIB, CELG, CRIS, IMMU, IMGN, INFI, MEDX, MNTA, ONCY, PFE, PCYC, SUPG, TELK, THLD)
Published:
Last Updated:
This weekend will be a potentially important oncology and cancer news weekend for drug and biotech stocks. The American Association for Cancer Research Meeting will actually have a 100th annual meeting, and some traders and investors may be using this as a preview for what lies ahead at the American Society of Clinical Oncology (ASCO) annual meeting in a month. The following companies which are presenting data:
- Allos Therapeutics, Inc. (NASDAQ: ALTH)
- Amgen (NASDAQ: AMGN)
- ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA)
- Array BioPharma, Inc. (NASDAQ: ARRY)
- AstraZeneca’s (NYSE: AZN) Medimmune unit
- Biogen Idec Inc. (NASDAQ: BIIB)
- Celgene Corporation (NASDAQ: CELG)
- Curis, Inc. (NASDAQ: CRIS)
- Immunomedics, Inc. (Nasdaq: IMMU)
- ImmunoGen, Inc. (Nasdaq: IMGN)
- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI)
- Medarex, Inc. (Nasdaq: MEDX)
- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA)
- Oncolytics Biotech, Inc. (NASDAQ: ONCY)
- Pfizer (NYSE: PFE)
- Pharmacyclics, Inc. (NASDAQ: PCYC)
- SuperGen Inc. (NASDAQ:SUPG)
- Telik, Inc. (Nasdaq: TELK)
- Threshold Pharmaceuticals, Inc. (Nasdaq: THLD)
You can see a full summary of the data being presented at BioHealthInvestor.com site. There will be others presenting data this weekend, and these were from the press releases of the meeting ahead of time.
JON C. OGG
Are You Ahead, or Behind on Retirement? (sponsor)
If you’re one of the over 4 Million Americans set to retire this year, you may want to pay attention.
Finding a financial advisor who puts your interest first can be the difference between a rich retirement and barely getting by, and today it’s easier than ever. SmartAsset’s free tool matches you with up to three fiduciary financial advisors that serve your area in minutes. Each advisor has been carefully vetted, and must act in your best interests. Start your search now.
Don’t waste another minute; get started right here and help your retirement dreams become a retirement reality.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.